Login / Signup
Sertac Ak
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Replacement Therapy
Advanced Non Small Cell Lung Cancer
Prognostic Factors
Ejection Fraction
Top Venues
Future oncology (London, England)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Saadettin Kılıçkap
,
Sertac Ak
,
Oldac U Dursun
,
Mehmet Ali Nahit Şendur
,
Nuri Karadurmus
,
Umut Demirci
Safety of lorlatinib in ALK-positive non-small-cell lung cancer and management of central nervous system adverse events.
Future oncology (London, England)
(2023)